Synergistic Inhibition of <i>Candida albicans</i> by Cranberry Proanthocyanidins and Probiotics: Novel Strategies for Vulvovaginal Candidiasis Treatment

Vulvovaginal candidiasis (VVC) is a common gynecological condition primarily caused by <i>Candida albicans</i>. The excessive use of antifungal drugs has led to increased drug resistance, necessitating the search for alternative therapies. This study investigates the synergistic antifung...

Full description

Saved in:
Bibliographic Details
Main Authors: Yu-Ru Wu, Jung-Sheng Chen, Lei-Chin Chen, Laura Chen, Yu-Fen Huang, Chien-Sen Liao
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Series:Pathogens
Subjects:
Online Access:https://www.mdpi.com/2076-0817/14/4/308
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Vulvovaginal candidiasis (VVC) is a common gynecological condition primarily caused by <i>Candida albicans</i>. The excessive use of antifungal drugs has led to increased drug resistance, necessitating the search for alternative therapies. This study investigates the synergistic antifungal effects of cranberry proanthocyanidins (PACs) and probiotics against <i>C. albicans</i>. PACs were prepared at different concentrations (low, medium, high) and tested alone and in combination with multi-strain probiotics, including <i>Lactobacillus rhamnosus</i> and <i>Lactobacillus plantarum</i>. The antifungal activity of their cell-free supernatants (CFS) was also assessed. The results demonstrated that the combination of <i>L. plantarum</i> and medium-concentration PACs (L.p. + PACs M) significantly enhathe inhibitionition of <i>C. albicans</i> compared to individual treatments. In the Vaginal Microbiota Communities Analysis, this condition reduced <i>C. albicans</i> relative abundance to below 0.01%. This study highlights the potential of natural compounds and probiotics as alternative therapeutic strategies for VVC.
ISSN:2076-0817